期 |
栏目 |
标题 |
文件 |
卷 15, 编号 2 (2013) |
Articles |
Prognostic value of p53 expression in patients with stage I breast cancer |
|
卷 15, 编号 3 (2013) |
Articles |
Prognosticheskoe znachenie lokal'nogo i sistemnogo lecheniya pri rake molochnoy zhelezy I stadii |
|
卷 15, 编号 3 (2013) |
Articles |
Rezul'taty «Epidemiologicheskoy programmy skrininga HER2-statusa u bol'nykh rakom molochnoy zhelezy» v Rossiyskoy Federatsii |
|
卷 16, 编号 2 (2014) |
Articles |
The results of Epidemiological HER2 screening program in patients with breast cancer in 2013 |
|
卷 17, 编号 1 (2015) |
Articles |
Immunological heterogeneity of stage I breast cancer:biological, population-based and prognostic value (international cooperation experience) |
|
卷 17, 编号 2 (2015) |
Articles |
The role and assessment of morphological regression after neoadjuvant therapy in breast cancer patients |
|
卷 17, 编号 3 (2015) |
Articles |
The results of Epidemiological HER2 screening program in patients with breast cancer in 2014 |
|
卷 20, 编号 4 (2018) |
Articles |
Quality control of immunohistochemical analyzes in Russia: yesterday, today, tomorrow |
(Rus)
|
卷 23, 编号 1 (2021) |
CLINICAL ONCOLOGY |
Breast cancer |
(Rus)
|